Dosimetric Comparison and Feasibility of Simultaneous Integrated Boost (SIB) in Treatment of Malignant Gliomas Using Intensity Modulated Radiotherapy (IMRT) or Volumetric Modulated Arc Therapy (VMAT)

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2018 Sep 27

PMID 30256043

Citations 1

Authors

Pragna Sagar Rapole

Gunaseelan Karunanithi

Saravanan Kandasamy

Sathiya Prabhu

Ram Kumar

S Vivekanandam

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the dosimetric parameters of Simultaneous Integrated Boost in the treatment of malignant gliomas and compare the SIB plans of VMAT and IMRT. Methodology: CT and MRI of 28 patients were used for generating SIB plans with VMAT and IMRT. A dose of 2Gy per fraction was prescribed to the CPTV and 2.4Gy to the GPTV for a total of 25 fractions. The plans were accepted only if they met the set of planning objectives defined in the protocol. Results: We could achieve the planning objectives in all the SIB plans. Although GPTV coverage was statistically better in VMAT (98.67% vs 98.19% ;p=0.024) the difference is not clinically meaningful. The conformity index for GPTV was higher in IMRT (0.83 vs 0.76; p=0.001). The coverage of CPTV was better in IMRT (97.88% vs 96.87%; p=0.021). But the conformity index of CPTVannulus was higher in VMAT (0.72 vs 0.67; p=0.01). There was no difference in homogeneity index of GPTV and CPTV annulus between the plans. The mean dose received by normal brain was higher in IMRT (28Gy vs 24.2Gy; p<0.001). Ipsilateral optic nerve has received lesser Dmax in IMRT (44.2Gy vs 46.95Gy; p=0.02). No difference was seen in Dmax of brainstem, optic chiasm, contralateral optic nerve. The treatment times and monitor units were significantly less in VMAT. Conclusion: SIB is dosimetrically feasible for hypofractionation in malignant gliomas using IMRT and VMAT. IMRT plans had better boost conformity, lower ipsilateral optic nerve and brainstem maximum doses compared to VMAT. Whereas, VMAT had better coverage, better overall PTV conformity, lower normal brain mean dose, lower monitor units and lesser treatment times. Although planning of VMAT is cumbersome and time consuming, the advantage of reducing treatment time is beneficial to the patients’ comfort and better managing of patient load in high volume centres.

Citing Articles

A Diamond-Based Dose-per-Pulse X-ray Detector for Radiation Therapy.

Pettinato S, Girolami M, Olivieri R, Stravato A, Caruso C, Salvatori S Materials (Basel). 2021; 14(18).

PMID: 34576426 PMC: 8466252. DOI: 10.3390/ma14185203.

References

Nakamatsu K, Suzuki M, Nishimura Y, Kanamori S, Koike R, Shibata T . Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy. Int J Clin Oncol. 2008; 13(1):48-53. DOI: 10.1007/s10147-007-0722-6. View

Hermanto U, Frija E, Lii M, Chang E, Mahajan A, Woo S . Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain?. Int J Radiat Oncol Biol Phys. 2007; 67(4):1135-44. DOI: 10.1016/j.ijrobp.2006.10.032. View

Cho K, Kim J, Lee S, Yoo H, Shin S, Moon S . Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas. Int J Radiat Oncol Biol Phys. 2010; 78(2):390-7. DOI: 10.1016/j.ijrobp.2009.08.029. View

Chan M, Schupak K, Burman C, Chui C, Ling C . Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme. Med Dosim. 2003; 28(4):261-5. DOI: 10.1016/j.meddos.2003.08.004. View

Wagner D, Christiansen H, Wolff H, Vorwerk H . Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol. 2009; 93(3):593-6. DOI: 10.1016/j.radonc.2009.10.002. View

Teoh M, Clark C, Wood K, Whitaker S, Nisbet A . Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011; 84(1007):967-96. PMC: 3473700. DOI: 10.1259/bjr/22373346. View

Mohan R, Wu Q, Manning M, Schmidt-Ullrich R . Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000; 46(3):619-30. DOI: 10.1016/s0360-3016(99)00438-1. View

Iuchi T, Hatano K, Kodama T, Sakaida T, Yokoi S, Kawasaki K . Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2014; 88(4):793-800. DOI: 10.1016/j.ijrobp.2013.12.011. View

Holt A, Van Gestel D, Arends M, Korevaar E, Schuring D, Kunze-Busch M . Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study. Radiat Oncol. 2013; 8:26. PMC: 3599974. DOI: 10.1186/1748-717X-8-26. View

10.

Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin P . Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. Int J Radiat Oncol Biol Phys. 2006; 64(3):892-7. DOI: 10.1016/j.ijrobp.2005.05.067. View

11.

Nguyen K, Cummings D, Lanza V, Morris K, Wang C, Sutton J . A dosimetric comparative study: volumetric modulated arc therapy vs intensity-modulated radiation therapy in the treatment of nasal cavity carcinomas. Med Dosim. 2013; 38(3):225-32. DOI: 10.1016/j.meddos.2013.01.006. View

12.

Kelly P, Daumas-Duport C, Scheithauer B, Kall B, Kispert D . Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc. 1987; 62(6):450-9. DOI: 10.1016/s0025-6196(12)65470-6. View

13.

Marks L, Yorke E, Jackson A, Ten Haken R, Constine L, Eisbruch A . Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S10-9. PMC: 4041542. DOI: 10.1016/j.ijrobp.2009.07.1754. View

14.

Thilmann C, Zabel A, Grosser K, Hoess A, Wannenmacher M, Debus J . Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer. 2001; 96(6):341-9. DOI: 10.1002/ijc.1042. View

15.

Cozzi L, Dinshaw K, Shrivastava S, Mahantshetty U, Engineer R, Deshpande D . A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008; 89(2):180-91. DOI: 10.1016/j.radonc.2008.06.013. View

16.

Suzuki M, Nakamatsu K, Kanamori S, Okumra M, Uchiyama T, Akai F . Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy (IMRT). Jpn J Clin Oncol. 2003; 33(6):271-7. DOI: 10.1093/jjco/hyg053. View

17.

Shaffer R, Nichol A, Vollans E, Fong M, Nakano S, Moiseenko V . A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys. 2009; 76(4):1177-84. DOI: 10.1016/j.ijrobp.2009.03.013. View

18.

Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W . Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol. 2008; 9(4):367-75. DOI: 10.1016/S1470-2045(08)70098-6. View

19.

Cha J, Suh C, Park K, Chang J, Lee K, Kim S . Feasibility and outcomes of hypofractionated simultaneous integrated boost-intensity modulated radiotherapy for malignant gliomas: a preliminary report. Yonsei Med J. 2013; 55(1):70-7. PMC: 3874925. DOI: 10.3349/ymj.2014.55.1.70. View

20.

Farzin M, Molls M, Astner S, Rondak I, Oechsner M . Simultaneous integrated vs. sequential boost in VMAT radiotherapy of high-grade gliomas. Strahlenther Onkol. 2015; 191(12):945-52. DOI: 10.1007/s00066-015-0888-1. View